278 related articles for article (PubMed ID: 8159751)
1. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.
Sprecher CA; Kisiel W; Mathewes S; Foster DC
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3353-7. PubMed ID: 8159751
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning, expression, and characterization of bovine tissue factor pathway inhibitor-2.
Du X; Deng FM; Chand HS; Kisiel W
Arch Biochem Biophys; 2003 Sep; 417(1):96-104. PubMed ID: 12921785
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
4. Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains.
Girard TJ; Gailani D; Broze GJ
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):923-8. PubMed ID: 7980463
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI).
Chang JY; Monroe DM; Oliver JA; Liles DK; Roberts HR
Thromb Haemost; 1998 Feb; 79(2):306-9. PubMed ID: 9493581
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
8. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
Hamamoto T; Kisiel W
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
[TBL] [Abstract][Full Text] [Related]
9. Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI.
Kamei S; Kamikubo Y; Hamuro T; Fujimoto H; Ishihara M; Yonemura H; Miyamoto S; Funatsu A; Enjyoji K; Abumiya T
J Biochem; 1994 Apr; 115(4):708-14. PubMed ID: 8089087
[TBL] [Abstract][Full Text] [Related]
10. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
Lockett JM; Mast AE
Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
[TBL] [Abstract][Full Text] [Related]
11. Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6.
Miyagi Y; Yasumitsu H; Mizushima H; Koshikawa N; Matsuda Y; Itoh H; Hori TA; Aoki I; Misugi K; Miyazaki K
DNA Cell Biol; 1996 Nov; 15(11):947-54. PubMed ID: 8945635
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory properties of human recombinant Arg24-->Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2).
Kamei S; Petersen LC; Sprecher CA; Foster DC; Kisiel W
Thromb Res; 1999 May; 94(3):147-52. PubMed ID: 10326761
[TBL] [Abstract][Full Text] [Related]
13. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
[TBL] [Abstract][Full Text] [Related]
14. Structure and biology of tissue factor pathway inhibitor.
Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
Petersen LC; Bjørn SE; Olsen OH; Nordfang O; Norris F; Norris K
Eur J Biochem; 1996 Jan; 235(1-2):310-6. PubMed ID: 8631347
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
Cunningham AC; Hasty KA; Enghild JJ; Mast AE
Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors.
Sprecher CA; Morgenstern KA; Mathewes S; Dahlen JR; Schrader SK; Foster DC; Kisiel W
J Biol Chem; 1995 Dec; 270(50):29854-61. PubMed ID: 8530382
[TBL] [Abstract][Full Text] [Related]
18. TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene.
Chang JY; Monroe DM; Oliver JA; Roberts HR
Thromb Haemost; 1999 Jan; 81(1):45-9. PubMed ID: 9974373
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
[TBL] [Abstract][Full Text] [Related]
20. The effect of leukocyte elastase on tissue factor pathway inhibitor.
Higuchi DA; Wun TC; Likert KM; Broze GJ
Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
